Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced it has completed its previously announced acquisition of Kolltan Pharmaceuticals, Inc., a privately held ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE